A test that measures kappa immunoglobulin free light chains in cerebrospinal fluid (KCSF) is a valid option for diagnosing multiple sclerosis (MS), new research suggests. Results showed that compared ...

A visual evoked potential (VEP) test is one test that a doctor may use to diagnose multiple sclerosis and monitor disease treatment and progression. Your brain and spinal cord make up your central ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says. Blood levels of a protein called neurofilament light chain rise ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Elecsys Neurofilament Light Chain (NfL) test for multiple sclerosis (MS). Made by Roche, the test is ...

The test that was developed using an existing diagnostic procedure as its basis and has the potential to be applied in clinical trials that target the Epstein Barr Virus. A team of research scientists ...

Please provide your email address to receive an email when new articles are posted on . MSDA Test disease activity scores range from 1 (low) to 10 (high). Areas under the curve included 0.81 for Gd+ ...

The eSDMT enables frequent remote cognitive assessments for pwMS, shifting from cross-sectional to longitudinal evaluation frameworks. The study showed strong concurrent validity and test-retest ...

Misdiagnoses of multiple sclerosis (MS) represent one of the prominent challenges in MS for patients, clinicians, and researchers. A variety of factors influence misdiagnosis, including testing ...

Add Yahoo as a preferred source to see more of our stories on Google. A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says.